Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 162,732 |
|
|||||
| News | - | ||||||
| Day High | 45.53 | Low High |
|||||
| Day Low | 40.36 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc | CRBP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 3.64 | 8.80% | 45.02 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 40.97 | 40.36 | 45.53 | 45.02 | 41.38 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,938 | 162,732 | US$ 44.16 | US$ 7,186,261 | - | 3.0334 - 50.42 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:52:05 | 1 | US$ 44.17 | USD |
Corbus Pharmaceuticals (CRBP) Options Flow Summary
Corbus Pharmaceuticals Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 468.83M | 10.49M | - | 0 | -44.6M | -4.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Corbus Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 45.81 | 50.42 | 40.36 | 45.57 | 212,385 | -0.79 | -1.72% |
| 1 Month | 33.33 | 50.42 | 32.27 | 42.42 | 216,089 | 11.69 | 35.07% |
| 3 Months | 30.81 | 50.42 | 30.3648 | 40.44 | 279,291 | 14.21 | 46.12% |
| 6 Months | 4.14 | 50.42 | 4.00 | 30.57 | 536,872 | 40.88 | 987.44% |
| 1 Year | 10.86 | 50.42 | 3.0334 | 29.92 | 273,834 | 34.16 | 314.55% |
| 3 Years | 53.10 | 68.70 | 2.11 | 18.45 | 1,237,891 | -8.08 | -15.22% |
| 5 Years | 219.00 | 322.50 | 2.11 | 64.02 | 2,191,317 | -173.98 | -79.44% |
Corbus Pharmaceuticals Description
| Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. |
